Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sanjay J Mathew

Showing results (81-90 of 190) with videos related to

Pageof 19
Sort By:
Biological Psychiatry|November 10, 2009
Safety and efficacy of repeated-dose intravenous ketamine for treatment-resistant depressionMarije aan het Rot, Katherine A Collins, James W Murrough, et al.
Journal of Affective Disorders|April 7, 2019
Trajectories of self-reported sleep disturbance across inpatient psychiatric treatment predict clinical outcome in comorbid major depressive disorder and generalized anxiety disorderElizabeth M Hartwig, Katrina A Rufino, Cara A Palmer, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 22, 2023
Correction: Neural complexity EEG biomarkers of rapid and post-rapid ketamine effects in late-life treatment-resistant depression: a randomized control trialNicholas Murphy, Amanda J F Tamman, Marijn Lijffijt, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 9, 2017
The Nucleus Accumbens and Ketamine Treatment in Major Depressive DisorderChadi G Abdallah, Andrea Jackowski, Ramiro Salas, et al.
Chronic Stress (Thousand Oaks, Calif.)|March 28, 2022
A Novel Approach to Link Genetics and Human MRI Identifies AKAP7-Dependent Subicular/Prefrontal Functional Connectivity as Altered in SuicidalityGuillermo Poblete, Tien Nguyen, Savannah Gosnell, et al.
Neuroimage. Clinical|February 7, 2014
Reduced hippocampal N-acetyl-aspartate (NAA) as a biomarker for overweightJeremy D Coplan, Hassan M Fathy, Chadi G Abdallah, et al.
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging|October 17, 2017
Prefrontal Connectivity and Glutamate Transmission: Relevance to Depression Pathophysiology and Ketamine TreatmentChadi G Abdallah, Christopher L Averill, Ramiro Salas, et al.
The Journal of Clinical Psychiatry|May 28, 2020
Efficacy of Esketamine Augmentation in Major Depressive Disorder: A Meta-AnalysisGeorge I Papakostas, Naji C Salloum, Rebecca S Hock, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 15, 2020
A randomized cross-over trial to define neurophysiological correlates of AV-101 N-methyl-D-aspartate receptor blockade in healthy veteransNicholas Murphy, Nithya Ramakrishnan, Bylinda Vo-Le, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 19, 2015
Prefrontal cortical GABA abnormalities are associated with reduced hippocampal volume in major depressive disorderChadi G Abdallah, Andrea Jackowski, João R Sato, et al.
Pageof 19

Showing results (81-90 of 190) with videos related to

Sort By:
Pageof 19
Biological Psychiatry|November 10, 2009
Safety and efficacy of repeated-dose intravenous ketamine for treatment-resistant depressionMarije aan het Rot, Katherine A Collins, James W Murrough, et al.
Journal of Affective Disorders|April 7, 2019
Trajectories of self-reported sleep disturbance across inpatient psychiatric treatment predict clinical outcome in comorbid major depressive disorder and generalized anxiety disorderElizabeth M Hartwig, Katrina A Rufino, Cara A Palmer, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 22, 2023
Correction: Neural complexity EEG biomarkers of rapid and post-rapid ketamine effects in late-life treatment-resistant depression: a randomized control trialNicholas Murphy, Amanda J F Tamman, Marijn Lijffijt, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 9, 2017
The Nucleus Accumbens and Ketamine Treatment in Major Depressive DisorderChadi G Abdallah, Andrea Jackowski, Ramiro Salas, et al.
Chronic Stress (Thousand Oaks, Calif.)|March 28, 2022
A Novel Approach to Link Genetics and Human MRI Identifies AKAP7-Dependent Subicular/Prefrontal Functional Connectivity as Altered in SuicidalityGuillermo Poblete, Tien Nguyen, Savannah Gosnell, et al.
Neuroimage. Clinical|February 7, 2014
Reduced hippocampal N-acetyl-aspartate (NAA) as a biomarker for overweightJeremy D Coplan, Hassan M Fathy, Chadi G Abdallah, et al.
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging|October 17, 2017
Prefrontal Connectivity and Glutamate Transmission: Relevance to Depression Pathophysiology and Ketamine TreatmentChadi G Abdallah, Christopher L Averill, Ramiro Salas, et al.
The Journal of Clinical Psychiatry|May 28, 2020
Efficacy of Esketamine Augmentation in Major Depressive Disorder: A Meta-AnalysisGeorge I Papakostas, Naji C Salloum, Rebecca S Hock, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 15, 2020
A randomized cross-over trial to define neurophysiological correlates of AV-101 N-methyl-D-aspartate receptor blockade in healthy veteransNicholas Murphy, Nithya Ramakrishnan, Bylinda Vo-Le, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 19, 2015
Prefrontal cortical GABA abnormalities are associated with reduced hippocampal volume in major depressive disorderChadi G Abdallah, Andrea Jackowski, João R Sato, et al.
Pageof 19